Scarica l'app Stockscreener
2.70
3.05%
0.08
Dopo l'orario di chiusura:
2.75
0.05
+1.85%
Precedente Chiudi:
$2.62
Aprire:
$2.64
Volume 24 ore:
687.50K
Relative Volume:
2.40
Capitalizzazione di mercato:
$77.85M
Reddito:
-
Utile/perdita netta:
$-14.14M
Rapporto P/E:
-2.9348
EPS:
-0.92
Flusso di cassa netto:
$-12.64M
1 W Prestazione:
+4.65%
1M Prestazione:
+35.00%
6M Prestazione:
+71.97%
1 anno Prestazione:
+87.50%
Intervallo 1D:
$2.61
$2.83
Intervallo di 1 settimana:
$2.31
$2.83
Portata 52W:
$1.34
$3.12
Immix Biopharma Inc Stock (IMMX) Company Profile
Nome
Immix Biopharma Inc
Settore
Industria
Telefono
(888) 958-1084
Indirizzo
11400 WEST OLYMPIC BLVD., LOS ANGELES
Confronta IMMX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMMX
Immix Biopharma Inc
|
2.70 | 81.93M | 0 | -14.14M | -12.64M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Immix Biopharma Inc Borsa (IMMX) Ultime notizie
Is Immix Biopharma Inc. still worth holding after the dipGap Up & Stepwise Entry and Exit Trade Signals - newser.com
Risk adjusted return profile for Immix Biopharma Inc. analyzedOptions Play & Fast Gain Stock Trading Tips - newser.com
How to monitor Immix Biopharma Inc. with trend dashboardsWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
Will Immix Biopharma Inc. benefit from macro trends2025 Bull vs Bear & Growth Focused Entry Point Reports - newser.com
Is Immix Biopharma Inc. stock poised for growth2025 Stock Rankings & Precise Swing Trade Entry Alerts - newser.com
How to integrate Immix Biopharma Inc. into portfolio analysis toolsWeekly Trend Report & Smart Money Movement Alerts - newser.com
Is Immix Biopharma Inc. reversing from oversold territoryCPI Data & Weekly Setup with High ROI Potential - newser.com
Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference - The Manila Times
Immix Biopharma, Inc. to Present at Guggenheim Healthcare Innovation Conference on November 11, 2025 - Quiver Quantitative
Nov 11 Fireside Chat 12:30 ET — Immix Biopharma to Present at Guggenheim Healthcare Conference - Stock Titan
Why Immix Biopharma Inc. stock could benefit from AI revolution2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - newser.com
Using AI based signals to follow Immix Biopharma Inc.2025 Price Targets & Low Risk Entry Point Tips - newser.com
What analysts say about Immix Biopharma Inc stockSector-Based Investing & Low Cost Wealth Strategies - earlytimes.in
Using flow based indicators on Immix Biopharma Inc.July 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - newser.com
Published on: 2025-10-10 06:23:37 - newser.com
Multi factor analysis applied to Immix Biopharma Inc.July 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Analyzing drawdowns of Immix Biopharma Inc. with statistical tools2025 Volume Leaders & AI Driven Stock Movement Reports - newser.com
Will Immix Biopharma Inc. stock outperform growth indexesWall Street Watch & Reliable Intraday Trade Alerts - newser.com
Immix Biopharma's (IMMX) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Comparing Immix Biopharma (NASDAQ:IMMX) & Candel Therapeutics (NASDAQ:CADL) - Defense World
Is Immix Biopharma Inc a good long term investmentLong-Term Investment Plans & Exceptional Profit Trading - earlytimes.in
Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting - GlobeNewswire
Immix Biopharma, Inc. to Present NXC-201 Abstract at ASH 67th Annual Meeting - Quiver Quantitative
NXC-201 Abstract: Immix Biopharma to Present at ASH 67th Annual Meeting in Orlando Dec 6-9, 2025 - Stock Titan
Why Immix Biopharma Inc. stock appeals to analysts2025 Historical Comparison & Reliable Volume Spike Alerts - newser.com
Measuring Immix Biopharma Inc.’s beta against major indicesAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com
Immix Biopharma Inc. stock chart pattern explainedEntry Point & Verified Short-Term Plans - newser.com
Analyzing Immix Biopharma Inc. with multi timeframe chartsMarket Trend Review & Free Real-Time Volume Trigger Notifications - newser.com
Will breakout in Immix Biopharma Inc. lead to full recoveryMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
Immix Biopharma to Present at the 37th Annual Piper Sandler Healthcare Conference - The Manila Times
Immix Biopharma, Inc. to Host Investor Meetings at 37th Annual Piper Sandler Healthcare Conference - Quiver Quantitative
Clinical-Stage Cell Therapy Developer ImmixBio to Showcase AL Amyloidosis Pipeline at Major Healthcare Conference - Stock Titan
Immix Biopharma Inc Azioni (IMMX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Immix Biopharma Inc Azioni (IMMX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Morris Gabriel S | CFO |
Sep 16 '25 |
Buy |
1.97 |
2,600 |
5,122 |
290,659 |
| Rachman Ilya M | CEO and Chairman |
Jun 18 '25 |
Buy |
2.29 |
2,178 |
4,999 |
1,138,437 |
| Morris Gabriel S | CFO |
Jun 18 '25 |
Buy |
2.28 |
2,225 |
5,071 |
288,059 |
| Hsu Jason | Director |
Dec 23 '24 |
Buy |
2.19 |
40,000 |
87,680 |
893,000 |
| Hsu Jason | Director |
Dec 20 '24 |
Buy |
2.17 |
7,700 |
16,678 |
853,000 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):